1-(tert-Butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate

Catalog No. :
ACJZPL290
CAS No. :
1201186-72-2
Molecular Formula :
C12H22N2O4
Molecular Weight :
258.32

IUPAC Name:1-(tert-butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate

1-(tert-Butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$500.00Login to see priceIn stockInquiry
250mg95%$781.00Login to see priceIn stockInquiry
500mg95%$1031.00Login to see priceIn stockInquiry
1g95%$1406.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate
IUPAC Name1-(tert-butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate
MDL No.MFCD29085525
Molecular FormulaC12H22N2O4
Molecular Weight258.32
SMILESO=C(N1C[C@H](C(OC)=O)N(C)CC1)OC(C)(C)C
InChI KeyCXJROCRSZVELMK-SECBINFHSA-N
Synonym1-(tert-butyl) 3-methyl (R)-4-methylpiperazine-1,3-dicarboxylate;1,3-Piperazinedicarboxylic acid, 4-methyl-, 1-(1,1-dimethylethyl) 3-methyl ester, (3R)-;Methyl (R)-4-Boc-1-methylpiperazine-2-carboxylate
CAS No.1201186-72-2

Synthetic Route by SureRoute

1. ACJZPL290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACJZPL290 route product structure diagram
    ACJZPL2901201186-72-2 In Stock
Inquiry

2. ACJZPL290 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBJGE630 route compound structure diagram
    ACBJGE630438631-77-7 In Stock
  4. Then
  5. ACJZPL290 route product structure diagram
    ACJZPL2901201186-72-2 In Stock
Inquiry

Comments (0)